Topical treatment may prevent melanoma

April 26, 2011 in Cancer

While incidents of melanoma continue to increase despite the use of sunscreen and skin screenings, a topical compound called ISC-4 may prevent melanoma lesion formation, according to Penn State College of Medicine researchers.

"The steady increase in incidence suggests that additional preventive approaches are needed to complement these existing strategies," said Gavin Robertson, Ph.D., professor of pharmacology, pathology, dermatology and surgery, and director of Penn State Hershey Melanoma Center.

Researchers targeted the protein Akt3, which plays a central role in 70 percent of melanoma by preventing cell death and has the potential to prevent early stages of melanoma.

"The Akt3 signaling pathway is deregulated in the majority of melanomas, making it a promising target which, if inhibited, could correct the apoptotic -- or cell death -- defect in melanocytic lesions, thereby preventing this disease," Robertson said.

Isothiocyantes were identified as inhibitors of Akt3. These are naturally occurring compounds found in cruciferous vegetables like broccoli and brussels sprouts that have anticancer properties. Unfortunately, previous research showed they have low chemotherapy potency on because high concentrations are needed to be effective. To create a more potent version, Penn State Hershey Melanoma Center researchers previously developed isoselenocyanates (ISC-4), by replacing sulfur with selenium.

Researchers have now found that repeated topical application of ISC-4 can reduce tumor in laboratory-generated human skin by 80 to 90 percent and decrease in mice skin by about 80 percent. The research also showed that the use of the compound is safe. The research was recently reported in Cancer Prevention Research and featured on the journal cover.

To be an effective preventative agent, a substance needs to kill the melanoma cells while having little effect on normal cells. Researchers learned that ISC-4 kills melanoma cells two to five times more effectively than it kills normal cells. In addition, examination of the treated skin showed no obvious damage to skin cells or skin structure, and treated animals did not show signs of major organ-related toxicity. This indicates a potential for use as a topical application.

"ISC-4 prevented melanoma by decreasing Akt3 signaling that led to a three-fold increase in apoptosis rates," Robertson said. "Thus, topical ISC-4 can delay or slow down melanocytic lesion or melanoma development in preclinical models and could impact melanoma incidence rates, if similar results are observed in humans."

Currently, surgical excision is used to remove melanocytic lesions or prevent development into more aggressive cancer. Topical ISC-4 treatment could potentially be an alternative to surgery for some patients.

"Topical or localized treatments, such as those we propose for ISC-4, could permit the use of high local concentrations with minimal toxicity and be useful for treating cutaneous lesions not amenable to surgical removal or other currently available approaches," Robertson said.

"With more than $1 billion spent on sunscreen every year in the United States, the market for skin cancer prevention is enormous and continues to grow," Robertson said. "Addition of agents such as ISC-4 to sunscreens, body lotions or creams could have a profound impact on this market for preventing melanoma."

Provided by Pennsylvania State University search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Math and dyslexia?
    created15 hours ago
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • A couple of questions about schizophrenia
    createdMay 17, 2012
  • Paralyzed woman uses thoughts to move robotic arm
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Do bald men face higher risk of prostate cancer?

(HealthDay) -- Got hair? If you don't, you might have a higher risk of prostate cancer, a preliminary study suggests.

Cancer created 1 hour ago | popularity not rated yet | comments 0 | with audio podcast

Researchers present new findings for novel pancreatic cancer vaccine

A novel pancreatic cancer vaccine shows promise in improving survival when added to standard treatment, according to new research out of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Researchers create new anti-cancer drug

A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers ...

Cancer created 5 hours ago | popularity 5 / 5 (1) | comments 0

New protein signature of breast cancer progression identified

A protein signature that predicts overall survival in breast cancer patients has been uncovered in the most comprehensive survey of protein expression patterns in breast cancer progression to date.

Cancer created 7 hours ago | popularity not rated yet | comments 0

Recommendation against PSA test too drastic: WU expert

(Medical Xpress) -- A new recommendation issued today by the U.S. Preventive Services Task Force against routine PSA testing for healthy men age 50 and older goes too far, says a prostate cancer expert at the Siteman Cancer ...

Cancer created 8 hours ago | popularity not rated yet | comments 0


Body building, diet supplements linked to liver damage: study

(HealthDay) -- Body-building and weight-loss products are the types of dietary supplements most likely to cause liver injury, according to a small new study.

Limits to growth: Scientists identify key metastasis-enabling enzyme

(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development ...

Asthma medication linked with arrhythmias in children, young adults

Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a study conducted by researchers at the University of ...

U.S. liver transplants declining

(HealthDay) -- The number of liver transplants in the United States has decreased since 2006, a new study finds.

Neuron-nourishing cells appear to retaliate in Alzheimer's

When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers ...

Researchers spearhead groundbreaking research into treatment of brain swelling

Researchers at Trinity College Dublin have reported the results of groundbreaking research into the prevention of cerebral oedema or swelling of the brain, a major cause of death in people who have sustained a traumatic injury ...